Articles
-
Texas Ruling Over Obamacare is Wrong to Claim That Without the Insurance Mandate, the Healthcare Law Can’t Survive
The Affordable Care Act’s insurance markets are stable, even without a penalty for those who don’t have coverage.
Categorized in -
NIH Awards USC School of Pharmacy, Price School of Public Policy 5-Year Grant to Support Minority Aging Research in Schaeffer Center
The $2.7 million award funds scholars pursuing research in health disparities in aging with an emphasis on Alzheimer’s disease.
-
The Trump Administration Side-Stepped Rulemaking Processes on the ACA’s State Innovation Waivers— And it Could Make Their New Section 1332 Guidance Invalid
Claims that the guidance is procedurally invalid open up potential new avenues for litigation surrounding section 1332 in general and could also become relevant to challenges regarding an approved waiver.
Categorized in -
Most Hospitals Receive Failing Score in at Least One Quality Dimension of Their Community Health Needs Assessment
Developing clearer guidelines for measuring a hospital’s orientation toward population health would be a big step towards fundamentally improving population health and changing the relationship between a hospital and its community.
Categorized in -
AJMC Names Erin Trish as the 2018 Recipient of the Seema S. Sonnad Emerging Leader in Managed Care Research Award
The award recognizes an individual whose early achievements in managed care demonstrate the potential for making an exceptional long-term contribution in the field.
-
Mortality Risk, Insurance, and the Value of Life
People with shorter life expectancies place more value on increases in survival than people who anticipate longer life spans.
Categorized in -
Some Blood Pressure Medications May Reduce Risk of Alzheimer’s, But Not For All Populations
Certain antihypertensive medications may prevent the onset of the disease, but only among black and white women and white men.
-
The Bigger Message Behind Amgen’s Decision to Slash Cost of its Repatha Cholesterol Drug
Drug companies look to haggle less and sell more, and that could cost Express Scripts, CVS Health and UnitedHealth writes Goldman in MarketWatch.
Categorized in -
White House Signs Bills Banning Gag Clauses, Schaeffer Center Research Pivotal in Discussion
Schaeffer Center report found 23 percent of private claims analyzed involved a copayment that exceeded the insurer’s cost of the drug.
-
PODCAST: The Healthcare Issues Voters Care About in the 2018 Midterms
Fellow Matthew Fiedler reviews the Trump administration’s changes to the ACA, Medicaid expansion and how often candidates are talking about health policy.
Categorized in